Vimarsana.com

Latest Breaking News On - Human genome sciences - Page 3 : vimarsana.com

MaxCyte Announces CEO Transition and Updates Revenue Guidance for 2023

Doug Doerfler, President and CEO, to Retire Effective December 31, 2023; will continue to serve as an advisor to MaxCyte Maher Masoud, EVP, Head of Global Business Development and Chief Counsel,.

United-kingdom
Chris-welsh
Mary-jane-elliott
David-deuchler
Panmure-gordon
Emma-earl-freddy-crossley
Doug-doerfler
Maher-masoud
Richard-douglas
Rupert-dearden
Glen-research
Michigan-state-university-college-of-law

Ceremorphic Life Sciences Demonstrates New Bio-Supercomputing Platform That Can Speed Every Phase of Drug Discovery and Development

Ceremorphic Life Sciences Demonstrates New Bio-Supercomputing Platform That Can Speed Every Phase of Drug Discovery and Development
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.

Boston
Massachusetts
United-states
Venkat-mattela
William-haseltine
Professor-at-harvard-medical-school
Human-genome-sciences
Ceremorphic-inc
Ceremorphic-life-sciences
Drug-discovery-summit
Life-sciences
Silico-models

Ceremorphic Life Sciences CEO Delivers Keynote at AI Driven Drug Discovery Summit; Demonstrates New Bio-supercomputing Platform that Can Speed Every Phase of Drug Discovery and Development

Ceremorphic Life Sciences CEO Delivers Keynote at AI Driven Drug Discovery Summit; Demonstrates New Bio-supercomputing Platform that Can Speed Every Phase of Drug Discovery and Development
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Boston
Massachusetts
United-states
Venkat-mattela
William-haseltine
Ceremorphic-inc
Ceremorphic-life-sciences
Professor-at-harvard-medical-school
Human-genome-sciences
Drug-discovery-summit
Demonstrates-new-bio-supercomputing-platform
Can-speed-every-phase

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q3 2023 Earnings Call Transcript

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q3 2023 Earnings Call Transcript November 14, 2023 Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Third Quarter 2023 Conference Call. An audio recording of the webcast will be available shortly after the call today on DiaMedica’s website at www.diamedica.com, in the Investor Relations section. Before the […]

China
Netherlands
Australia
Canada
Canadian
Australian
Dutch
Scott-kellen
Rick-pauls
Dave-wambeke
Qambar-shah
Pfizer

vimarsana © 2020. All Rights Reserved.